Experienced in Necrosis

Stefan P. Muller

Frankfurt Am Main, HE, DE 
Experienced in Necrosis
Frankfurt Am Main, HE, DE 
OverviewLocationsClinical Research

Overview

Stefan Muller practices in Frankfurt Am Main, Germany. Mr. Muller is rated as an Experienced expert by MediFind in the treatment of Necrosis. His top areas of expertise are Teratoma of the Mediastinum, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Non-Hodgkin Lymphoma.

His clinical research consists of co-authoring 126 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Necrosis.

Gender
Male

Locations

Frankfurt Am Main, HE 60590, Germany
Other Locations
Heidelberg, BW 69120, Germany
Bochum, NW 44780, Germany
Wuerzburg, BY 97074, Germany
Essen, NW 45147, Germany
Koeln, NW, Germany
Hamburg, HH 21073, Germany
Duisburg, NW 47057, Germany
Marburg An Der Lahn, HE, Germany
Freiburg, BW, Germany
Luebeck, SH 23562, Germany
Giessen, HE, Germany
Rostock, MV 18057, Germany
Regensburg, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III Clinical Trial of Intra-arterial TheraSphere® in the Treatment of Patients With Unresectable Hepatocellular Carcinoma (HCC)
A Phase III Clinical Trial of Intra-arterial TheraSphere® in the Treatment of Patients With Unresectable Hepatocellular Carcinoma (HCC)
Enrollment Status: Completed
Publish Date: November 08, 2023
Intervention Type: Device
Study Phase: Not Applicable

126 Total Publications

Genetic alterations of SENP6 in multiple myeloma disrupt genome and proteome stability, sensitizing to proteasome inhibition.
Genetic alterations of SENP6 in multiple myeloma disrupt genome and proteome stability, sensitizing to proteasome inhibition.
Journal: Haematologica
Published: September 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Muller's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile